Last updated on January 2010

Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)


Brief description of study

Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)

Detailed Study Description

A Multicenter, Open-Label Evaluation of Treatment Satisfaction, Tolerability, Safety, and Preference of Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated with Triptans

Patient Inclusion Criteria:

  • Men or Women 18 to 65 years of age
  • Have a history of 2 to 6 migraine headaches (on average) per month
  • Suffering from Migraines for more than one (1) year before first office visit
  • Willing to stop or discontinue current treatment for Migraines Headaches
  • Diagnosis of Migraine Headaches before the age of 50
  • Be Fluent in English

Patient Exclusion Criteria:

  • Can not read or understand English Forms
  • History of Epilepsy or Seizure or any other Neurologic Condition
  • HIV/AIDS, Cancer or Hepatitis C (detectable or undetectable)
  • Hemiplegic or Basilar Migraines
  • Terminal Illnesses
  • Uncontrolled Cardiovascular Diseases (Uncontrolled Hypertension)
  • Minors (under the legal age of 18)
  • Older than the permitted age of 65

Clinical Study Identifier: TX134653

Find a site near you

Start Over

University Clinical Research, Inc.

1150 N University Drive Pembroke Pines, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.